Literature DB >> 6509797

Polymorphonuclear leucocyte locomotion and aggregation in patients with alcoholic liver disease.

I A Rajkovic, A G Yousif-Kadaru, R J Wyke, R Williams.   

Abstract

Defects in stimulated movement of polymorphonuclear (PMN) leucocytes was detected in 57% of patients with alcoholic liver disease. Serum from patients with the cellular defect had no effect on the function of normal PMN leucocytes. Aggregation responses of patients' PMN leucocytes suggest that the cellular defect may be related to specific abnormalities in the response to the C5a chemotactic factor. Defective serum attractant activity was found in 65% of the patients tested and the presence in the patients serum of humoral directed antagonists appeared to be responsible for the defect in majority of cases. Further analysis pointed to the presence of at least two distinct antagonists and the possible involvement of proteases in this serum abnormality. The activity of the serum antagonists or the severity of the cellular defect were unrelated to the presence of bacterial infection or elevations in serum IgA or IgG. The high frequency of cellular defects, possibly as a result of in vivo activation, in conjunction with serum abnormalities could account for the increased susceptibility of patients with alcoholic liver disease to bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509797      PMCID: PMC1577110     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Spontaneous colon bacillus bacteremia in Laennec's cirrhosis.

Authors:  W A TISDALE
Journal:  Gastroenterology       Date:  1961-01       Impact factor: 22.682

2.  B. coli septicemia in Laennec's cirrhosis of the liver.

Authors:  R L WHIPPLE; J F HARRIS
Journal:  Ann Intern Med       Date:  1950-08       Impact factor: 25.391

3.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

4.  Defective chemotaxis associated with a serum inhibitor in cirrhotic patients.

Authors:  A N DeMeo; B R Andersen
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

5.  Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.

Authors:  D E Hammerschmidt; T K Bowers; C J Lammi-Keefe; H S Jacob; P R Craddock
Journal:  Blood       Date:  1980-06       Impact factor: 22.113

6.  Bacteraemia in association with hepatocellular and hepatobiliary disease.

Authors:  E A Jones; S Sherlock; N Crowley
Journal:  Postgrad Med J       Date:  1967-03       Impact factor: 2.401

7.  Neutrophil adherence in chronic liver disease and fulminant hepatic failure.

Authors:  M Altin; I A Rajkovic; R D Hughes; R Williams
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

8.  Circulating lysosomal enzymes and acute hepatic necrosis.

Authors:  C D Gove; E N Wardle; R Williams
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

Review 2.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Influence of the acute alcoholism on the phagocytic function of the mononuclear phagocytic system.

Authors:  K R Sabino; A Petroianu; L R Alberti
Journal:  J Med Life       Date:  2011-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.